Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that
the convertible loan agreement had been entered into. All closing conditions
have now been met and satisfied and closing of the convertible bond transaction
has been completed.
The initial conversion price, NOK 0.7330 per share, was correctly stated in the
notice, but the calculation basis should have been phrased as follows: "The
initial conversion price will be NOK 0.7330 per share, which is 125% of the
lowest volume weighted average price (VWAP) of the shares on the six days up to
(and including) the signing date (being 22 December 2023)."
Contact person
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com (mailto:marianne.boe@idexbiometrics.com)
Tel: +47 9180 0186
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com)
About this notice
This notice was published by Erling Svela, Vice president of finance, on 28
December 2023 at 22:55 CET on behalf of IDEX Biometrics ASA. The information
shall be disclosed according to section 5?9 of the Norwegian Securities Trading
Act (STA) and published in accordance with section 5?12 of the STA.